Free Trial

Day One Biopharmaceuticals (DAWN) SEC Filings & 10K Form

Day One Biopharmaceuticals logo
$13.31 -1.01 (-7.05%)
(As of 11/15/2024 ET)

Recent Day One Biopharmaceuticals SEC Filings

DateFilerForm TypeView
11/08/2024
3:15 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
8:24 AM
Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/07/2024
8:12 AM
Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G
11/04/2024
4:24 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:48 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
4:53 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
4:59 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
5:07 PM
Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
5:12 PM
Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:17 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
4:23 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2024
6:35 AM
Day One Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
6:04 AM
Day One Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
5:04 AM
Day One Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
3:32 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/05/2024
5:11 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
6:17 PM
Day One Biopharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
3:14 PM
Day One Biopharmaceuticals (Subject)
Ramasastry Saira (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
7:36 AM
Day One Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
3:29 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
7:07 AM
Day One Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2024
7:35 AM
Day One Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
5:44 PM
Day One Biopharmaceuticals (Issuer)
Grossman William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
5:48 PM
Day One Biopharmaceuticals (Issuer)
Garland J. Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
5:24 PM
Day One Biopharmaceuticals (Issuer)
Josey John A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
5:27 PM
Day One Biopharmaceuticals (Issuer)
Nicholson Garry A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
5:31 PM
Day One Biopharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
5:13 PM
Dable Habib J (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
5:17 PM
Day One Biopharmaceuticals (Issuer)
Gladstone Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
5:21 PM
Day One Biopharmaceuticals (Issuer)
Holles Natalie C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
3:02 PM
Day One Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2024
5:11 PM
Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
5:15 PM
Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
5:18 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
5:27 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:21 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
5:29 PM
Day One Biopharmaceuticals (Subject)
York Charles N II (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
5:34 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
5:43 PM
Day One Biopharmaceuticals (Subject)
Dubow Adam (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2024
5:13 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
3:35 PM
Day One Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
There is a little known company that is changing warfare (Ad)

With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t
05/06/2024
3:30 PM
Day One Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
5:44 PM
Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:48 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
7:01 AM
Day One Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
5:36 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
5:09 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:24 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:55 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
5:48 PM
Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
5:36 PM
Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
5:14 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
5:26 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:51 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
7:50 AM
Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
Day One Biopharmaceuticals (Subject)
Form SC 13G
01/19/2024
4:19 PM
Dable Habib J (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
4:22 PM
Day One Biopharmaceuticals (Issuer)
Grossman William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
4:01 PM
Dable Habib J (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/19/2024
4:09 PM
Day One Biopharmaceuticals (Issuer)
Grossman William (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/17/2024
7:25 AM
Day One Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
6:25 PM
Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
6:29 PM
Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
6:17 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
6:22 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
7:30 AM
Day One Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:06 PM
Day One Biopharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/17/2023
5:20 PM
Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
5:26 PM
Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
5:30 PM
Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
5:33 PM
Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
6:07 AM
Day One Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DAWN) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners